Clinical Trial Update: Optimized Heparin Regimen in Vascular Surgery [NA]

View source ↗

Summary

A CHUM-sponsored clinical trial evaluating an optimized heparin regimen in vascular surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Peripheral Revascularisation | NA | Status: COMPLETED